Economic evaluation of Danhong injection for the treatment of chronic stable angina in China: A cost-effectiveness analysis
Abstract. Objective. Danhong injection (DHI) is commonly used in China to treat chronic stable angina (CSA), demonstrating significant clinical efficacy and safety. The present study aimed to estimate the cost-effectiveness of DHI combined with standard treatment (ST) compared with ST alone in patie...
Saved in:
| Main Authors: | Pengli Su, Kai Zhi, Jing Xiao, Huanhuan Xu, Jun Liu, Zhong Wang, Yanan Yu, Haixia Dang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2024-12-01
|
| Series: | Science of Traditional Chinese Medicine |
| Online Access: | http://journals.lww.com/10.1097/st9.0000000000000050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of Danhong injection on inflammatory factors and vascular endothelial function in patients with unstable angina pectoris: a systematic review and meta-analysis of randomized clinical trials
by: Zunqi Kan, et al.
Published: (2025-06-01) -
Danhong Injection Inhibits Apoptosis in Ischemia/Reperfusion Injury Based on Network Pharmacology Analysis, Molecular Docking, and Experimental Verification
by: Shennan Shi, et al.
Published: (2025-02-01) -
Efficacy of danhong injection adjuvant therapy in patients with acute ischemic stroke: a real-world, multicenter, retrospective study
by: Danping Pan, et al.
Published: (2025-06-01) -
Evaluating Symptoms to Improve Quality of Life in Patients with Chronic Stable Angina
by: Jeffrey W. Young, et al.
Published: (2013-01-01) -
GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS
Published: (2016-01-01)